In line with The Galleria Al Maryah Island’s support of the national vaccination programme and its dedication to providing a safe environment for the community, we are proud to announce that an onsite COVID-19 vaccination booth operated by Mubadala Health is open to the public at The Galleria Al Maryah Island. This joins the existing PCR testing facility operated by Abu Dhabi Stem Cells Centre (ADSCC) which opened late last year. This announcement reinforces The Galleria’s commitment to health and safety by making critical services accessible to the community.

COVID-19 Vaccination Centre

  • Administers the UAE government approved Sinopharm COVID-19 vaccine.
  • Operates on an appointment only basis to ensure social distancing.
  • Appointments can be made by emailing: mcv@telemed.ae or calling: 8004959. An eligibility survey will be administered before the first appointment is confirmed.
  • The second appointment will be made on-site after the first shot has been administered.
  • Currently open to UAE citizens and residents 16 years of age or older.
  • Patients must present a valid Emirates ID and have the AlHosn app downloaded on their mobiles.
  • Vitals will be taken prior to administering the vaccine, and individuals will be observed afterwards for a few minutes for any reactions.
  • Vaccination is free.
  • Located on the Concourse Level near Waitrose.
  • Timings: Sunday to Thursday from 10:00am – 7:00pm. 

COVID-19 PCR Test Facility

  • Located on the Concourse Level near Waitrose.
  • Results sent via SMS within 24-48 hours.
  • Fee: AED 85 per test.
  • Timings: 9:00am – 10:00pm daily.
  • For more information, please call Abu Dhabi Stem Cells Centre on: 800 3008.

For more information about the Mubadala Health COVID-19 vaccine booth and the ADSCC PCR testing facility, please visit www.thegalleria.ae  or follow @TheGalleriaUAE.

-Ends-

Media Contacts:
Weber Shandwick MENAT
Sahar Makki
SMakki@webershandwick.com

Rowan Saghayroun
RSaghayroun@webershandwick.com 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.